______Chapters_____
00:00 - Intro -
00:02:34 - Case 1 - The CF center of Tübingen, Germany, Dr Philipp Utz (Pediatric pulmonologist).
00:10:47 - Case 1 - The CF center of Tübingen, Germany, Barbara Räwer (Physiotherapist).
00:21:00 - Cases 2 & 3 - Teesside CF Service (Middlesbrough, UK), Dr Raj Jayaraj (Consultant respiratory paediatrician) & Claire Lord (Specialized physiotherapist).
00:39:59 - Case 4 - The Institute of Tuberculosis and Lung Diseases, Rabka-Zdrój, Poland, Dr Karolina Gwoździewicz & Katarzyna Warzeszak (Physiotherapist).
00:57:35 - Discussion -

Here is the replay of the first Virtual Roundtable: Reinforcement of intravenous antibiotic therapy by sessions with SIMEOX during bronchopulmonary treatment. The clinical benefits for the patient.

We are proud and thankful to have been able to gather 8 experienced clinical teams from 5 different European countries to share their experience on the use of Simeox at each stage of the care of the CF patient.
Because we believe best practices & clinical experience sharing as well as peer-to-peer interaction is of extreme value to show the place, impact and benefits of the Simeox therapy in the respiratory care management pathway of Cystic Fibrosis patients.

#cysticfibrosis #simeox

свернуть